StockWatch
·
Pharmaceuticals
Quarterly Result19 May 2026, 07:22 pm

Viyash Scientific: FY26 PAT up 1324% to ₹2,246 Million

AI Summary

Viyash Scientific Ltd (formerly Sequent Scientific Limited) announced its financial results for the period ended March 31, 2026. Q4 FY26 revenues reached ₹9,200 Million, up by 19.1%, with EBITDA at ₹2,001 Million, up 63.8%. FY26 revenues were ₹34,203 Million, up by 13.8%, and EBITDA at ₹7,025 Million, up 59.6%. FY26 PAT increased by 1324% to ₹2,246 Million. The company will conduct an earnings call on May 20, 2026.

Key Highlights

  • Q4 FY26 revenues increased by 19.1% to ₹9,200 Million.
  • Q4 FY26 EBITDA increased by 63.8% to ₹2,001 Million.
  • FY26 revenues grew by 13.8% to ₹34,203 Million.
  • FY26 EBITDA increased by 59.6% to ₹7,025 Million.
  • FY26 PAT surged by 1324% to ₹2,246 Million.